Blog

ARA-290 (Cibinetide): Benefits, Mechanism, and Clinical Research Explained

Chronic inflammation, neuropathic pain, and tissue damage are at the core of many age-related and autoimmune conditions. While existing therapies often focus on symptom management, researchers have been exploring peptides that can actively protect and repair tissues at the cellular level. One of the most promising in this field is ARA-290, also known as Cibinetide. ARA-290 […]

Blog

Dihexa Peptide: Benefits, Mechanism, and Cognitive Risks Explained

The search for compounds that can enhance memory, learning, and brain repair has led researchers into the world of neuropeptides. While most nootropics work by tweaking neurotransmitters or improving blood flow, Dihexa takes a different approach. Developed by researchers at Washington State University, this synthetic peptide is designed to stimulate the growth of new synaptic connections […]

Blog

Survodutide: Dual GLP-1/Glucagon Peptide for Obesity and MASH Explained

Obesity and liver disease are two of the fastest-growing health challenges worldwide. While GLP-1 drugs like semaglutide (Ozempic®, Wegovy®) have changed the landscape of weight-management, researchers are now looking for next-generation therapies that go beyond appetite suppression. One of the most promising is Survodutide (BI 456906), a peptide currently in late-stage clinical trials. Survodutide is a […]